Celanese CFO Buys Into the Dip Before Q3 Results

The most concrete signal into Celanese's Q3 earnings report is the CFO's own money. Chuck Kyrish, SVP and CFO, made three open-market purchases on August 14 totalling 2,300 shares at around $45.50, spending roughly $104,000 without a pre-arranged trading plan. A day earlier, the SVP and General Counsel added 600 shares at $45.60, and the SVP of Acetyls bought 2,153 shares worth about $98,000. That cluster of discretionary buying from operating executives, not grants or plan-driven sales, is the sharpest signal in the dataset heading into the print.

The Street is more divided. The consensus leans cautiously constructive, with the mean price target around $61, implying roughly 27% upside from the current price of $47.94. Bulls argue that a macro recovery in automotive and electronics could push EBITDA toward $2.5 billion, supported by favorable pricing in the Western Hemisphere. Bears point to the previous quarter's EBITDA of $326 million coming in despite a 2% revenue decline, and to demand for non-tow acetyl products in the Western Hemisphere reaching its weakest levels in roughly two decades. Barclays initiated coverage in October at Equal-Weight with a $49 target, essentially in-line with where the stock trades now. The broader analyst direction since mid-year has been one of target cuts: Morgan Stanley trimmed to $58 from $72 in July, BMO Capital moved from $80 to $57, and Wells Fargo dropped from $80 to $65 after the last print. RBC raised its target modestly to $46 just before this report, still below the current price.

Short sellers have been pulling back. CE short interest fell nearly 10% over the past week to around 5.2% of the free float, close to its lowest level in at least a year. The borrow market is exceptionally loose: availability is running at roughly 2,517%, meaning shares to borrow dwarf current short demand by a wide margin. Cost to borrow is 0.47%, down about 17% on the month. There is no squeeze pressure here, and no sign of escalating bearish conviction from the lending market.

One standout from the ownership register is Norges Bank Investment Management, which added around 8.9 million shares in the quarter ending June 30, lifting its disclosed stake to 8.5% of shares. Dodge and Cox remains the largest holder at nearly 14%, with no change reported. The Vanguard Group, which previously held 10.74% under a single 13G filing, reported zero shares in a March 2026 amendment, though two separate Vanguard-affiliated entities each carry 13G filings of around 5% filed in April 2026, reflecting a structural reorganisation rather than an exit. All 13D/G positions are as last disclosed and holders dropping below 5% may not file again.

Wikipedia attention for Celanese is running more than two standard deviations above its own 90-day average, according to ORTEX Alt Data, suggesting a spike in retail interest around the earnings date.

The print will test whether the CFO's August conviction around the $45 price level was an early read on stabilising demand, or simply a floor that the results themselves now need to validate.